First Continental Review of the Global Compact for Safe, Orderly and Regular Migration Concludes in Africa | United Nations Economic Commission for Africa
uneca.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uneca.org Daily Mail and Mail on Sunday newspapers.
Слухи подтвердились: Канье Уэста и Ирину Шейк поймали на свидании hronika info
hronika.info - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hronika.info Daily Mail and Mail on Sunday newspapers.
Plan B : la petite-fille de Jacques Higelin dans la dernière série TF1
linternaute.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from linternaute.com Daily Mail and Mail on Sunday newspapers.
Flare Therapeutics, a Cambridge, Mass. – based biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, raised $82m in Series A financing.
The round was led by Third Rock Ventures with participation from Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors and Eventide Asset Management.
The company intends to use the funds for further advancement of its lead program in precision oncology toward the clinic proprietary assays to discover small molecules that target transcription factors at switch sites.
Led by Abbie Celniker, PhD, interim chief executive officer, Flare is a biotechnology company with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, the team has uncovered ‘switch sites,’ druggable regions that are key targets for transcription factor regulation to address m